Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday
I'm PortAI, I can summarize articles.
Kyverna Therapeutics shares surged 31% to $11.49 after announcing positive Phase 2 trial data for miv-cel in stiff person syndrome. Other notable stock gains include Beneficient up 29.3%, Immunome up 25.5% following positive Phase 3 trial results, and Almonty Industries up 9.1% after withdrawing a base shelf prospectus. Additional stocks like Falcon’s Beyond Global, XBP Global Holdings, and others also recorded gains on Monday.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments